Table 1.
Pre- and Postdifferences of the Selected Outcome Measurements
| Outcomes | Placebo | Capacitive | Resistive |
|---|---|---|---|
| IMBF, proximal (%) | |||
| Pre- and post 1-difference | 0.01 (0.7)a | 0.36 (4.4) | 0.53 (1.04) |
| Pre- and post 2-difference | 0.17 (1.6) | 0.79 (3.3)b | 2.2 (1.95) |
| Pre- and post 3-difference | 0.05 (1.1) | −0.09 (1.9) | 2.06 (3.3)a,b |
| IMBF, distal (%) | |||
| Pre- and post 1-difference | −0.2 (1.1) | 1.4 (4.06) | 1.4 (3.02) |
| Pre- and post 2-difference | 0.5 (1.9) | 0.5 (5.2) | 1.12 (3.95) |
| Pre- and post 3-difference | 0.1 (2.1) | 0.65 (1.13) | 1.5 (3.69) |
| Skin perfusion (%) PSMC | |||
| Pre- and postdifference | −24.8 (16.8)c,d | −3.97 (22.01)c | 23.1 (56.4)d |
| Heart rate (bpm) | |||
| Pre- and postdifference | −1 (7) | 1.5 (9) | 0.5 (10) |
| Mean arterial pressure (mmHg) | |||
| Pre- and postdifference | −4.2 (6) | −2.8 (6.3) | 0.65 (5) |
| Skin temperature (°) | |||
| Pre- and postdifference | −2.3 (1.5)e | 0.9 (1.3) | 2.8 (2)e |
All values are reported as median and IQR.
a–e
Indicate significant differences (p < 0.05) between groups.
IMBF, intramuscular blood flow; IQR, interquartile range; PSMC, perfusion of the skin microcirculation.